• Linkedin
  • Twitter
  • Pinterest
  • Vimeo
  • Skype
  • Gplus
  • Youtube
  • Rss
  • Home
  • Events
  • Careers at CAPTIS
  • Log In / Sign In ▼
    • Log In with LinkedIn
    • Register w/out LinkedIn
    • Login w/out LinkedIn
    • Reset Lost Password
  • 🔒 MEMBER AREA ▼
    • View your profile
    • Edit your profile
    • Log out
       ☎ US Offices 1 (800) 445-1839 Toll Free | Europe/Int'l +41 22 518 2100
CAPTIS Executive Search
  • Home
  • You are a Business
    • Executive Search
    • Our Commitments
    • Other Services
    • Our Locations
    • About Us
    • Key Values
  • You are a Healthcare Executive
    • Dealing with CAPTIS
    • Candidate Contact Form
    • Login with LinkedIn
    • Create an Account
    • Log in (Existing Account)
    • WW Trade Shows
      • Medical & Pharmaceutical
      • Orthopedics
      • Spine
      • Cardiovascular
      • Diagnostics
      • Wound Care
      • Plastic & Aesthetic Surgery
      • Surgery
      • Trauma
      • Pediatric Care
    • Industry News
      • News
      • Wall Street Beat
      • Business/Financial News
      • Clinical Trials
      • Musculoskeletal News Roundup
      • Cardiovascular
      • M&A Activity
      • Food & Drug Administration (FDA)
      • Wound Care
      • Practice Management
  • CAPTIS Magazine
    • Healthcare News
    • @CaptisCorp Twitter Timeline
    • Healthcare Events
    • CAPTIS LinkedIn Timeline
    • Articles ➜
      • Recruiting
      • Personal Development
      • News
  • Make an Inquiry
  • Contact Us
    • General Contact Form
    • Healthcare Executive Contact
    • Apply for a position at CAPTIS
    • Call 1 800 445 1839
      (Cell/Mobile US & Canada Toll Free, or Skype)
    • Call +41 22 518 2100
      (Cell/Mobile Swiss Landline Switchboard, or Skype)
  • Search
  • Menu

Captare. Aestimare. Eligere. Succedere.

CAPTIS – Your Global Healthcare & MedTech Executive Search Provider

You are a Business

You are an Executive

Want to work at CAPTIS

Learn about our services

 

 

Executive Search
Submit an inquiry

GET HEADHUNTED!

Create and/or update

your confidential profile

 

Healthcare Executive General Information
Create an account & Add your profile

Go to our Careers page

 

 

 

 

 

CAPTIS Careers

Recent Healthcare News:

03/25/2019/by CAPTIS

FDA clears Genetesis’ CardioFlux biomagnetic cardiac imager

Genetesis said last Friday it won FDA 510(k) clearance for its…
03/25/2019/by CAPTIS

Masimo wins FDA 510(k) for Rad-67 pulse co-oximeter

03/25/2019/by CAPTIS

Omron wins FDA nod for combined blood pressure monitor, EKG

03/25/2019/by CAPTIS

Elekta wins Health Canada approval for Elekta Unity MR radiation therapy system

03/25/2019/by CAPTIS

Thermo Fisher to drop $1.7B on gene therapy maker Brammer Bio

03/25/2019/by CAPTIS

FDA clears shorter protocol for Nexstim’s NBT TMS depression treatment

03/25/2019/by CAPTIS

CardioFocus wins CE Mark for HeartLight X3 endoscopic ablation system

03/25/2019/by CAPTIS

Report: Outgoing FDA head Gottlieb calls for better regulation of EHRs

03/25/2019/by CAPTIS

Study examines usability of hybrid closed-loop insulin pump

03/25/2019/by CAPTIS

Titan Medical, Teleflx ink collab robotic ligation dev deal

03/25/2019/by CAPTIS

Zimmer Biomet wins FDA nod for robotic Rosa One Spine platform

Zimmer Biomet (NYSE:ZBH) said today that it won FDA 510(k)…
03/25/2019/by CAPTIS

DeviceTalks partners with MassMEDIC to highlight the Massachusetts medical device ecosystem at DeviceTalks Boston

03/25/2019/by CAPTIS

Dutch regulators explain no-deal Brexit impact for medical device companies

03/25/2019/by CAPTIS

Janssen seeks expanded use of Darzalex combination therapy for patients with newly diagnosed multiple myeloma

03/25/2019/by CAPTIS

Thermo Fisher Scientific to buy viral vector CDMO Brammer Bio for $1.7bn

03/24/2019/by CAPTIS

bluebird bio opens gene and cell therapy manufacturing facility in North Carolina

03/22/2019/by CAPTIS

Smiths Group unveils Smiths Medical spinout plan, search for new CEO

03/22/2019/by CAPTIS

Wound Management buys out remaining 50% stake in Cellerate

03/22/2019/by CAPTIS

FDA panel: Neuronix Alzheimer’s therapy fails to prove efficacy

03/22/2019/by CAPTIS

Senseonics touts patient access program for Eversense CGM

Go to the Healthcare News

Recent news from your industry: Finance, M&A, Products, Companies and more…

Upcoming Events:

We Suggest:

Novartis plans Alcon spinout for early April

0 Comments
/
03/22/2019
Novartis (NYSE:NVS) said today that it’s planning to list…
Read more
https://www.captis.com/wp-content/uploads/2019/03/alcon-novartis-7x4-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-03-22 10:24:202019-03-22 10:31:09Novartis plans Alcon spinout for early April

Varex Imaging to pay $85m for Direct Conversion

0 Comments
/
03/22/2019
Varex Imaging (NSDQ:VREX) said yesterday it inked…
Read more
https://www.captis.com/wp-content/uploads/2019/03/varex-imaging-updated-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-03-22 08:50:332019-03-22 09:01:04Varex Imaging to pay $85m for Direct Conversion

Artificial intelligence and medicine: Is it overhyped?

0 Comments
/
03/22/2019
Artificial intelligence raises exciting possibilities for healthcare,…
Read more
https://www.captis.com/wp-content/uploads/2019/03/AI-hype-300x195.jpg 195 300 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-03-22 08:21:222019-03-22 08:31:11Artificial intelligence and medicine: Is it overhyped?

Dyve Bioscience touts proof-of-concept study for transdermal painkiller

0 Comments
/
03/22/2019
Dyve Bioscience this week touted data from a human proof-of-concept…
Read more
https://www.captis.com/wp-content/uploads/2019/03/dyve-bioscience-logo-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-03-22 06:55:012019-03-22 07:01:59Dyve Bioscience touts proof-of-concept study for transdermal painkiller

Neovasc shares tumble on 2018 earnings release

0 Comments
/
03/22/2019
Shares in Neovasc (NSDQ:NVCN) have fallen nearly 10% today…
Read more
https://www.captis.com/wp-content/uploads/2019/03/neovasc-small-150x86-3.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-03-22 06:50:192019-03-22 07:01:57Neovasc shares tumble on 2018 earnings release

Titan Medical closes $25m offering

0 Comments
/
03/22/2019
Robotic surgical platform developer Titan Medical (NSDQ:TMDI)…
Read more
https://www.captis.com/wp-content/uploads/2019/03/titanmedical-MD-150x81-1.jpg 81 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-03-22 05:55:552019-03-22 06:01:17Titan Medical closes $25m offering

Novartis launches COPD inhalers in China

0 Comments
/
03/22/2019
Novartis (NYSE:NVS) has launched its Ultibro Breezhaler…
Read more
https://www.captis.com/wp-content/uploads/2019/03/novartis-7x4-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-03-22 05:12:102019-03-22 05:31:32Novartis launches COPD inhalers in China

Novocure launches pivotal ovarian cancer trial

0 Comments
/
03/22/2019
Novocure (NSDQ:NVCR) said today that it kicked off a Phase…
Read more
https://www.captis.com/wp-content/uploads/2019/03/novocure-updated-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-03-22 04:39:532019-03-22 05:01:05Novocure launches pivotal ovarian cancer trial

Conatus announces top-line results from ENCORE-NF phase 2b clinical trial in NASH fibrosis

0 Comments
/
03/22/2019
The trial’s primary endpoint was a ≥1 CRN fibrosis stage…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-03-22 01:02:342019-03-22 01:02:35Conatus announces top-line results from ENCORE-NF phase 2b clinical trial in NASH fibrosis

GSK’s anti-BCMA antibody-drug conjugate improves ORR in cancer study

0 Comments
/
03/22/2019
The further positive data from the DREAMM-1 study, which is based…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-03-22 01:02:322019-03-22 01:02:33GSK’s anti-BCMA antibody-drug conjugate improves ORR in cancer study

Imago BioSciences announces $40m Series B financing led by Omega Funds

0 Comments
/
03/21/2019
Other investors participating in the round include existing investors…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-03-21 23:01:292019-03-21 23:01:30Imago BioSciences announces $40m Series B financing led by Omega Funds

Hemodialysis device maker Phraxis raises $6m

0 Comments
/
03/21/2019
Early stage medical device company Phraxis has raised approximately…
Read more
https://www.captis.com/wp-content/uploads/2019/03/phraxis-large-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-03-21 13:06:442019-03-21 13:31:59Hemodialysis device maker Phraxis raises $6m

Homeland Security details vulnerabilities in Medtronic ICD, CRT-Ds, CareLink devices

0 Comments
/
03/21/2019
The U.S. Dept. of Homeland Security today released a medical…
Read more
https://www.captis.com/wp-content/uploads/2019/03/medtronic-large-updated-150x97-7.png 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-03-21 12:06:192019-03-21 12:31:30Homeland Security details vulnerabilities in Medtronic ICD, CRT-Ds, CareLink devices

IceCure Medical touts interventional radiology cryoablation study data

0 Comments
/
03/21/2019
IceCure Medical yesterday released data from an interventional…
Read more
https://www.captis.com/wp-content/uploads/2019/03/icecure-large-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-03-21 11:12:102019-03-21 11:31:20IceCure Medical touts interventional radiology cryoablation study data

FDA approves Otimizer Smart heart failure device from Impulse Dynamics

0 Comments
/
03/21/2019
The FDA today said it approved the Optimizer Smart heart failure…
Read more
https://www.captis.com/wp-content/uploads/2019/03/impulse-dynamics-7x4-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-03-21 10:53:342019-03-21 11:01:21FDA approves Otimizer Smart heart failure device from Impulse Dynamics

Semtech, Sonova ink hearing aid development deal

0 Comments
/
03/21/2019
Sonova Holding AG (SIX:SOON) and semiconductor maker Semtech…
Read more
https://www.captis.com/wp-content/uploads/2019/03/sonova-large-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-03-21 09:11:362019-03-21 09:31:15Semtech, Sonova ink hearing aid development deal

Appeals court declines full review of $254m Zimmer loss to Stryker

0 Comments
/
03/21/2019
A federal appeals court declined a full review of its earlier…
Read more
https://www.captis.com/wp-content/uploads/2019/03/stryker-zimmer-1-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-03-21 08:54:272019-03-21 09:01:44Appeals court declines full review of $254m Zimmer loss to Stryker

Teleflex touts real-world UroLift study data

0 Comments
/
03/21/2019
Teleflex (NYSE:TFX) today released results from real-world…
Read more
https://www.captis.com/wp-content/uploads/2019/03/teleflex-small-150x86.png 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-03-21 08:22:502019-03-21 08:32:02Teleflex touts real-world UroLift study data

NE Ohio biomedical industry investments on the rise

0 Comments
/
03/21/2019
Investment in the northeast Ohio biomedical sector totaled nearly…
Read more
https://www.captis.com/wp-content/uploads/2019/03/money-caduceus-multiuse-300x195.jpg 195 300 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-03-21 08:11:472019-03-21 08:32:00NE Ohio biomedical industry investments on the rise

Appeals court reverses Organogenesis win in gender bias, retaliation lawsuit

0 Comments
/
03/21/2019
A U.S. federal appeals court this week reversed a win for Organogenesis…
Read more
https://www.captis.com/wp-content/uploads/2019/03/organogenesis-small-150x86.png 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-03-21 06:56:362019-03-21 07:01:16Appeals court reverses Organogenesis win in gender bias, retaliation lawsuit
PreviousNext

  • Thorough Network

  • Deep Knowledge

  • Comprehensive Process

  • Ethical Approach

  • Confidentiality

  • Assessment Capacity

99%

Percentage of successful project completion

85%

Of placed executives remain with the client company 3 or more years

  • Share on Facebook
  • Share on Twitter
  • Share on Google+
  • Share on Pinterest
  • Share on Linkedin
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail

News from Twitter

Twitter
CAPTIS
CAPTIS
@CaptisCorp

Let's meet at #AAOS2019 in Las Vegas. Feel free to make contact. pic.twitter.com/Cybu…

reply retweet favorite
4:11 pm · 03/14/2019
Twitter
Dr. Alfredo Figueiredo
Dr. Alfredo Figueiredo
@AlfredoFig1

#LowBackPain - a good summary by the European Spine Society @EUROSPINESoc eurospinepatientline… #Orthopaedics #SpineSurgery pic.twitter.com/yo6E…

reply retweet favorite
5:05 am · 02/21/2019 ·
Retweeted by CAPTIS
Twitter
CAPTIS
CAPTIS
@CaptisCorp

Happy President's Day from CAPTIS!

reply retweet favorite
5:06 pm · 02/18/2019
Twitter
Medtronic Spine
Medtronic Spine
@Medtronic_Spine

We are saddened to share the news of the passing of Dr. Yves Cotrel. A pioneer in modern spine surgery, Dr. Cotrel's company Sofamor, was the foundation for what would become Medtronic Spine. Dr. Cotrel's contributions will live on for years to come. Condolences to his family. pic.twitter.com/JJ1Z…

reply retweet favorite
5:27 pm · 02/01/2019 ·
Retweeted by CAPTIS
Twitter
Arab Health
Arab Health
@Arab_Health

The 44th edition of Arab Health is officially now open. #ArabHealth2019 runs until the 31st of January 2019 at the Dubai World Trade Centre and the Conrad Dubai from 10 am to 6 pm. Find out more on our website or download the Arab Health 2019 show app: bit.ly/2n3Z5Q pic.twitter.com/oasI…

reply retweet favorite
5:35 pm · 01/29/2019 ·
Retweeted by CAPTIS
Twitter
Novartis Cancer
Novartis Cancer
@NovartisCancer

Cancer is not a ‘one size fits all,’ nor is the way we treat it. We are working to better understand the different ways a cancer can mutate so we can discover new approaches to treat some of the most difficult-to-treat types of the disease. #ReimagineMedicine #ESMO18 pic.twitter.com/41QL…

reply retweet favorite
6:56 pm · 10/24/2018 ·
Retweeted by CAPTIS
Twitter
Epic CV
Epic CV
@Epic_CV

Read carefully employer's directions on how to apply. #resume #resumetips

reply retweet favorite
7:47 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
World Spine Care
World Spine Care
@WorldSpineCare

Here are 5 Tips to Avoid Back Pain from #WorldSpineDay. #Exercise #Posture #Stress #HealthyEating #Strength pic.twitter.com/AT1D…

reply retweet favorite
7:46 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Neurochecklists
Neurochecklists
@neurochecklists

Large-vessel giant cell arteritis: diagnosis, monitoring and management | Rheumatology | Oxford Academic academic.oup.com/rhe…

reply retweet favorite
7:40 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Stryker Endoscopy
Stryker Endoscopy
@StrykerEndo

Scientists have made an unexpected discovery while investigating the triggering factors of #ColonCancer: Cell stress in combination with an altered microbiota in the colon drives tumor growth. Learn more: ow.ly/JxtK30meLTY pic.twitter.com/U51Q…

reply retweet favorite
7:39 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Implantech
Implantech
@Implantech

If you are in Dallas attending the AAFPRS 12th International Symposium of Facial Plastic Surgery don’t miss out on this Breakfast Symposium tomorrow morning with Dr. William Binder that is sponsored by Implantech! #implantech #superiorpatientaesthetics #implantechrewards #aafprs pic.twitter.com/HCzK…

reply retweet favorite
7:38 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
American College of Cardiology
American College of Cardiology
@ACCinTouch

Less than one month left to submit your science for #ACC19! Abstract & case submissions are due Oct. 16. Learn more: ow.ly/4nyf30lYZxh pic.twitter.com/Mnwv…

reply retweet favorite
4:46 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
Novartis Cancer
Novartis Cancer
@NovartisCancer

With #CARTcell therapy, an inactive virus programs T cells with new genetic information to help recognize specific antigens found on normal cells and certain blood cancer cells. As the CAR-T cells multiply, new copies also gain this ability. #CARTCellStory pic.twitter.com/Xuoh…

reply retweet favorite
4:42 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
Integra LifeSciences
Integra LifeSciences
@integra_life

Make plans to visit the Integra LifeSciences Booth# 919 during Plastic Surgery The Meeting September 28th - October 1st. #Integra_LifeSciences #DurableIsBeautiful #PSTM18 #ASPS #PlasticSurgery pic.twitter.com/8QGv…

reply retweet favorite
4:42 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
Fundamental Surgery
Fundamental Surgery
@FundamentalSurg

We are live at #NASS2018 stand 2649. Get hands-on with the world's leading surgical #simulator in #VR with #haptics and experience the future of surgical training. #wearefundamental fundamentalsurgery.c… pic.twitter.com/NgzA…

reply retweet favorite
4:41 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
TRX Orthopedics
TRX Orthopedics
@TRXOrtho

Great things happening at Tissue Regenix! Plan to visit our booth at the AAOS meeting in New Orleans, under the CellRight Technologies banner #5413. @AAOS1

reply retweet favorite
8:34 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Corin Group
Corin Group
@corintechnology

All evaluation cases for the new Corin Dual Mobility option for the Trinity Acetabular cup system have now been completed and we're looking forward to the full launch. Click lnkd.in/g8ariEY for details #orthopaedics #technology #totalhip #uniquehip pic.twitter.com/SPsy…

reply retweet favorite
8:33 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Omar Ishrak
Omar Ishrak
@MedtronicCEO

Thank you to our @Medtronic employees around the globe! Q3 saw strong, balanced results, with diversified performance in all groups and regions. #MDTEarnings

reply retweet favorite
8:33 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Cardiovascular News
Cardiovascular News
@Cardiovasc_bio

#cardiovascular news CorFlow Presents Fundamental New Insights into the Coronary Microcirculation at ACC - CorFlow Therapeutics AG corflowtherapeutics.… today announced that the company will present fundamental new insights into the coronary microci... ow.ly/OlaG50gAElO

reply retweet favorite
8:32 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Integra LifeSciences
Integra LifeSciences
@integra_life

Welcome Sravan Emany, our new vice president, treasurer and head of investor relations. investor.integralife… pic.twitter.com/wzt5…

reply retweet favorite
8:31 pm · 03/02/2018 ·
Retweeted by CAPTIS
Follow @CaptisCorp

Follow CAPTIS



CAPTIS
Followon TwitterSubscribeto RSS Feed

We Recommend

Our very best and up-to-date selection of healthcare Industries' News (Products, Markets, Companies, R&D, Technology, Opportunities, Investment & Finance...).
Read at Healthcare News

CAPTIS Newsletter

Call CAPTIS

United States Offices
1 (800) 445-1839

(United States & Canada Toll Free)

Europe & International
+41 22 518 2100

© CAPTIS - Executive Search - 2017 - copyright@captis.com
  • Linkedin
  • Twitter
  • Pinterest
  • Vimeo
  • Skype
  • Gplus
  • Youtube
  • Rss
  • Events
  • For Healthcare Executives
  • Legal & Privacy Notes, GDPR & Cookies Policy
  • Client Area
X
Thank you for visiting our new website! Help us improve, let us know your feedback (Anonymous 2 min survey)
Survey
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OK, got itCookies Policy
Scroll to top